|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.83 USD | +4.88% |
|
+6.93% | -12.42% |
| 05-01 | UBS Adjusts Price Target on Exponent to $75 From $85, Maintains Neutral Rating | MT |
| 04-30 | Exponent, Inc., Q1 2026 Earnings Call, Apr 30, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 81.67 | +34.25% | 3 | ||||||
| 209.62 | +21.95% | 16 | ||||||
| 127.73 | +10.77% | 11 | ||||||
| 158.27 | +25.92% | 15 | ||||||
| 31.47 | +20.47% | 17 | ||||||
| 58.44 | +0.58% | 13 | ||||||
| 24.07 | +6.17% | 14 | ||||||
| 292.17 | +8.13% | 12 | ||||||
| 74.31 | +20.64% | 8 | ||||||
| 42.45 | +48.81% | 11 | ||||||
| - | 271.67 | +2.1% | 3 | |||||
| 41.75 | +60.58% | 8 | ||||||
| 153 | +62.61% | 2 | ||||||
| 78.15 | +51.4% | 13 | ||||||
| 1,364 | +27.84% | 5 | ||||||
| - | 50.27 | +16.28% | 3 | |||||
| 3.071 | +37.71% | 12 | ||||||
| - | 105 | +92.55% | 2 | |||||
| 51.86 | +14.05% | 7 | ||||||
| Average | 169.42 | +29.62% | 9 | ||||||
| Weighted average by Cap. | 163.83 | +22.14% | 13 |
- Stock Market
- Stocks
- EXPO Stock
- Sector Exponent, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
